OLMA (Olema Pharmaceuticals) OCF Yield %: -14.90 (As of Jun. 25, 2026)


OLMA Olema Pharmaceuticals inc OLMA
33 GF Score
Price $11.43
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals OCF Yield %?

Olema Pharmaceuticals OLMA +2.60% 33 OCF Yield % is -14.90 as of Jun. 25, 2026. GuruFocus rates OLMA with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 1,419 Biotechnology companies, Olema Pharmaceuticals ranks worse than 63% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Olema Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-148.72 Mil, and Market Cap is $998.38 Mil. Therefore, Olema Pharmaceuticals's OCF Yield % for today is -14.90%.

The historical rank and industry rank for Olema Pharmaceuticals's OCF Yield % or its related term are showing as below:

OLMA' s OCF Yield % Range Over the Past 10 Years
Min: -15.28   Med: 0   Max: -14.47
Current: -14.9


During the past 8 years, the highest OCF Yield % of Olema Pharmaceuticals was -14.47%. The lowest was -15.28%. And the median was %.

OLMA's OCF Yield % is ranked worse than
63% of 1419 companies
in the Biotechnology industry
Industry Median: -8.46 vs OLMA: -14.90

Olema Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Olema Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Olema Pharmaceuticals OCF Yield % Related Terms


Olema Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals OCF Yield % Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -13.61 -83.14 -10.85 -24.09 -7.21

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.47 -40.89 -20.55 -7.54 -14.13

OLMA vs AKTS, ZBIO, MNKD: OCF Yield % Comparison

For the Biotechnology subindustry, Olema Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olema Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Olema Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Olema Pharmaceuticals's OCF Yield % falls into.


OLMA
33GF Score
Olema Pharmaceuticals inc OLMA
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Olema Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-146.716 / 2034.4
=-7.21%

Olema Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-45.987 * 4 / 1302.13503
=-14.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -14.90 mean?
Olema Pharmaceuticals (OLMA) has a OCF Yield % of -14.90 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Olema Pharmaceuticals and its competitors. According to the industry distribution chart, Olema Pharmaceuticals ranks #894 out of 1419 companies in the Biotechnology industry, placing it in the top 63%.
Is Olema Pharmaceuticals' OCF Yield % too high?
Olema Pharmaceuticals' current OCF Yield % is -14.90. Based on the distribution chart, Olema Pharmaceuticals ranks #894 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Olema Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' OCF Yield % compare to AKTS and ZBIO?
According to the Biotechnology industry distribution chart, Olema Pharmaceuticals ranks #894 out of 1419 companies for OCF Yield %. This places Olema Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current OCF Yield % is -14.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current OCF Yield % of -14.90. The current OCF Yield % is -14.90. Olema Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current OCF Yield % is -14.90 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
33GF Score

Get the complete analysis for OLMA

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.43
Price